Gender-related differences in iron absorption by preadolescent children.
In a study of absorption of iron from meals by preadolescent children (Tanner stage 1), we had noted that erythrocyte incorporation of the extrinsic iron label was somewhat greater by girls than by boys. Although the difference was not significant, the observation seemed to warrant further study. Study A: A precisely determined quantity of ferrous sulfate enriched with the stable isotope 58Fe was given without food to 15 boys and 15 girls (Tanner stage 1) after an overnight fast and was immediately followed by a dose of 70 mg of ascorbic acid. 58Fe enrichment of the erythrocytes was determined by inductively coupled plasma mass spectrometry at baseline and 14 and 42 d after administration of the 58Fe dose. Geometric mean erythrocyte incorporation of the 58Fe label was 35.2% of intake by boys and 45.0% of intake by girls. The difference was significant (analysis of covariance with serum ferritin as covariate, p = 0.035). Study B: Fifteen boys and 15 girls (Tanner stage 1) were fed a breakfast labeled with 58Fe. Geometric mean erythrocyte incorporation of the 58Fe label was 14.8% of intake by boys and 24.7% of intake by girls. The difference was significant (analysis of covariance with serum ferritin as covariate, p = 0.004). Because serum ferritin concentrations were similar in boys and girls, the gender-related difference in iron absorption (as reflected by erythrocyte incorporation of the label) does not appear to be explained by a difference in body stores of iron. We hypothesize that hormonal differences between boys and girls in Tanner stage 1 favor iron absorption by girls.
Woodhead
J C
JC
Department of Pediatrics, College of Medicine, University of Iowa, Iowa City 52242.
Drulis
J M
JM
Nelson
S E
SE
Janghorbani
M
M
Fomon
S J
SJ
D001205:Ascorbic Acid / Q000494:pharmacology; D001827:Body Height; D001835:Body Weight; D002614:Chelating Agents / Q000494:pharmacology; D002648:Child; D005260:Female; D005293:Ferritins / Q000032:analysis; D005296:Ferrous Compounds / Q000493:pharmacokinetics*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D012727:Sex Characteristics; D012741:Sexual Maturation
D002614:Chelating Agents; D005296:Ferrous Compounds; C020748:ferrous sulfate; D005293:Ferritins; D001205:Ascorbic Acid